Abstracts tagged "Anti-TNF therapy and infection"

Abstract Number: 707 • 2016 ACR/ARHP Annual Meeting
Anti-TNF Drugs Are Not Associated with Increasead Risk of Hzv Infections in Patients with Spondyloarthritis (SpA): Results from the GISEA Registry
Fabiola Atzeni¹, Marco Sebastiani², Valentina Panetta³, Fausto Salaffi⁴, Florenzo Iannone⁵, Elisa Gremese⁶, Antonio Carletto⁷, Antonio Marchesoni⁸, Roberto Gorla⁹, Marcello Govoni¹⁰, Rosario Foti¹¹, Ennio G. Favalli¹², Roberta Ramonda¹³, Pier Carlo Sarzi-Puttini¹⁴, Giovanni Lapadula¹⁵ and Gianfranco Ferraccioli¹⁶, ¹Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy, ²SC Reumatologia, Dipartimento di Medicine, Medicina d’Urgenza e Specialità Mediche, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy, ³L'altrastatistica -Consultancy & Training- Biostatistics office., Rome, Italy, ⁴Rheumatology Department, Polytechnic University of Marche, C. Urbani Hospital, Jesi,, Ancona, Italy, ⁵Interdisciplinary Department of Medicine (DIM), Rheumatology Unit, University of Bari, General Hospital, Bari, Italy, ⁶Division of Rheumatology, Institute of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy, ⁷Rheumatology Unit, University of Verona, Verona, Italy, ⁸Department of Rheumatology, Gaetano Pini Institute, Milan, Italy, ⁹Rheumatology and Immunology Unit, Spedali Civili di Brescia, Brescia, Italy, ¹⁰Medical Sciences, UOC of Rheumatology, University Hospital S. Anna, Cona Ferrara, Italy, ¹¹Rheumatology Unit, Vittorio-Emanuele University Hospital of Catania, Catania, Italy, ¹²Department and Chair of Rheumatology, University of Milan, Gaetano Pini Institute, Milan, Italy, ¹³Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy, ¹⁴Rheumatology Unit, L. Sacco University Hospital, Milan, Italy, ¹⁵Rheumatology Unit, University of Bari, Bari, Italy, ¹⁶Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy
Background/Purpose: Herpes zoster virus (HZV) reactivation disproportionately affects patients with systemic rheumatic diseases and it is commonly described in short- and long-term use of anti-Tumor…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].